Titan Pharmaceuticals Clinical Trials
Sponsors / Titan Pharmaceuticals
Titan Pharmaceuticals appears as lead sponsor on 12 trial records in ClinicalTrials.gov. Of these, 0 are recruiting, 0 are active without new recruitment, and 5 have completed. The registry records 7 terminated or withdrawn trials for Titan Pharmaceuticals. The most common reasons cited for termination include safety concerns. Planned participant enrollment across these trials sums to 871. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.
12
Total Trials
0
Recruiting
0
Other Active
5
Completed
7
Terminated / Withdrawn
871
Total Enrollment
Termination reasons: Safety57% · Other43%
Recent Terminations
- Parkinson Disease"This study was terminated for reasons not related to efficacy or safety"
- Opioid Dependency"This study was terminated for reasons not related to efficacy or safety"
- Opioid Dependence"This study was terminated for reasons not related to efficacy or safety"
- Heart Failure, Congestive"Study terminated for reasons unrelated to safety or efficacy."
- Leukemia, Lymphocytic, Chronic
- Bladder Neoplasms
- Malignant Melanoma